Resverlogix files additional new patent protection for RVX-208
The new patent application was filed for novel dosing combinations of RVX-208 and leading statin therapeutics based on the analysis of the Phase II study data. The study
Made Scientific has acquired an 85,000ft² cell therapy manufacturing facility in Pennsylvania, US, from National Resilience, adding an operational site to its US East Coast network.